It is of major concern that although reducing the Bcl-xS/Bcl-xL ratio in diabetes would have therapeutic effects regarding β-cell apoptosis, a decrease in the Bcl-xS/Bcl-xL ratio at a whole-organism level may promote tumor cell survival. Here, BCL2L1 is linked to diabetes mellitus.